Study summary · research use only
[Changes of immune and non-specific reactivity in patients with chronic suppurative obstructive bronchitis in comprehensive treatment with thymogen]
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This report describes 33 patients with chronic pyoobstructive bronchitis who had immunological disorders (T-cell and other) and altered nonspecific responsiveness. The abstract reports that use of thymogen in multi-modality treatment was associated with normalization of T-cell immunity parameters (increases in E-rosette formation, blast cell transformation responses to phytohemagglutinin, Tx/Tc ratio) and nonspecific responsiveness parameters (C3c, NBT-test, natural killers), which the authors associate with a higher clinical outcome.
Abstract
A total of 33 patients with chronic pyoobstructive bronchitis with immunological disorders (of T-cell and other links) and nonspecific responsiveness. The use of thymogen in multi-modality treatment contributed to normalization of T-cell immunity (increases in E-rosette formation, responses of blast cell transformation to phytohemagglutinin, Tx/Tc ratio), as well as nonspecific responsiveness parameters (C3c, NBT-test, natural killers), resulting in higher clinical efficacy.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.